Compare uniQure N.V. Ordinary Shares (QURE) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Xpeng Inc - ADR — how do they compare? uniQure N.V. Ordinary Shares trades at $20.71 (market cap $1.45B), while Xpeng Inc - ADR trades at $9.46 (market cap $9.43B). The key difference: Xpeng Inc - ADR is far larger — about 6.5× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Xpeng Inc - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Xpeng Inc - ADR for 81 Days on average.
| QURE | XPEV | |
|---|---|---|
Market Cap | $1.45B | $9.43B |
Volume | 3,323,243 | 5,598,195 |
Sector | Health | Consumer Cyclical |
52-Week High | $70.59 | $28.07 |
52-Week Low | $9.03 | $9.25 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $707.46M | $11.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XPeng (XPEV) trades at $9.75, up 0.93% with bearish technical signals despite strong analyst support. The company shows improving fundamentals with revenue surging to $76.72B in 2025 and narrowing losses, though it remains unprofitable. Recent developments include strong Q3 2026 vehicle deliveries of 41,256 units and expansion into humanoid robotics and global markets through the Paris Motor Show launch.
XPeng presents a high-risk growth opportunity with significant upside potential based on analyst targets ($17.55 consensus) but faces execution risks in profitability turnaround and intense EV competition. The stock's valuation appears reasonable (P/S 0.8) but profitability metrics remain negative, requiring careful monitoring of margin improvement and cash flow sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
